Effect of Sacubitril-Valsartan on Transcriptomic Changes in Lung Tissue of Spontaneously Hypertensive Rats: A Multi-omics Study Based on RNA-Seq Transcriptome Analysis
American Journal of Hypertension · 2026
DOI: 10.1093/ajh/hpaf143 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Zhengxiang Lv und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Transcriptome, Aminobutyrates, Lung, Biphenyl Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Postdoctoral Science Foundation Grant of China, Natural Science Foundation Postdoctoral Program of Chongqing Science and Technology Bureau.
Abstract (Originalsprache)
BACKGROUND Hypertension, a prevalent cardiovascular disorder, exerts detrimental effects on the respiratory system. However, the underlying mechanisms remain incompletely elucidated. METHODS We conducted comparative transcriptomic profiling via RNA sequencing (RNA-seq) of lung tissues from spontaneously hypertensive rats (SHR) and normotensive Wistar–Kyoto (WKY) controls. Additionally, we assessed the effects of angiotensin receptor blocker (ARB) and angiotensin receptor-neprilysin inhibitor (ARNI) interventions on mRNA and protein expression profiles in SHR pulmonary tissue using integrated omics approaches. RESULTS Core differentially expressed genes (DEGs) identified in SHR versus WKY comparisons included Nuf2 and Cenpa, with significant enrichment in the PI3K/AKT signaling pathway. In SHR versus ARB-treated cohorts, hub genes Ccnb2 and Mad2l1 demonstrated primary pathway enrichment in cell-cycle regulation and human T-cell leukemia virus 1 infection. ARNI intervention yielded distinct hub genes (Gzma, Icam1) enriched in PI3K/AKT signaling and extracellular matrix (ECM)–receptor interactions. Proteomic analysis confirmed concordant expression patterns for EGFR and JUN proteins with transcriptomic findings. CONCLUSIONS ARB and ARNI therapies mitigate hypertension-induced pulmonary damage through divergent molecular mechanisms, with PI3K/AKT signaling and ECM–receptor interactions serving as central regulatory hubs in this protective process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Zhengxiang Lv
Förderung
- National Natural Science Foundation of China
- Postdoctoral Science Foundation Grant of China
- Natural Science Foundation Postdoctoral Program of Chongqing Science and Technology Bureau
- Natural Science Foundation of Chongqing Science and Technology Commission
- Chongqing Science and Technology Commission and Chongqing Health Committee
- Future Medicine Youth Innovation Team Development Support Program of Chongqing Medical University
- Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University
Zitieren
APA
Lv, Z., Dai, W., Rong, S., & Du, J. (2026). Effect of Sacubitril-Valsartan on Transcriptomic Changes in Lung Tissue of Spontaneously Hypertensive Rats: A Multi-omics Study Based on RNA-Seq Transcriptome Analysis. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf143
Vancouver
Lv Z, Dai W, Rong S, Du J. Effect of Sacubitril-Valsartan on Transcriptomic Changes in Lung Tissue of Spontaneously Hypertensive Rats: A Multi-omics Study Based on RNA-Seq Transcriptome Analysis. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf143
BibTeX
@article{Lv2026,
author = {Lv, Zhengxiang and Dai, Weiran and Rong, Shunkang and Du, Jianlin},
title = {Effect of Sacubitril-Valsartan on Transcriptomic Changes in Lung Tissue of Spontaneously Hypertensive Rats: A Multi-omics Study Based on RNA-Seq Transcriptome Analysis},
journal = {American Journal of Hypertension},
year = {2026},
doi = {10.1093/ajh/hpaf143}
}
EUVIMED